Systems-Pharmacology-Based Identification of Antitumor Necrosis Factor Effect in Mimeng Flower Decoction for the Treatment of Diabetic Retinopathy

<div>Flowchart of the systems pharmacology method in this study. BF, <i>Buddlejae Flos</i>; CR: <i>Coptidis Rhizoma</i>; CC, <i>Cinnanmomi Cortex</i>; HMM, <i>Hedysarum Multijugum Maxim.</i>; FLL, <i>Fructus Ligustri Lucidi</i>; MF, <i>Mume Fructus</i>; LH, <i>Leonuri Herba</i>.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Systems-Pharmacology-Based Identification of Antitumor Necrosis Factor Effect in Mimeng Flower Decoction for the Treatment of Diabetic Retinopathy 

Figure 1 | Systems-Pharmacology-Based Identification of Antitumor Necrosis Factor Effect in Mimeng Flower Decoction for the Treatment of Diabetic Retinopathy 